Sanofi SNY announced that the phase III IRAKLIA study, which evaluated a fixed-dose subcutaneous (SC) formulation of its ...

On Wednesday, Sanofi SA (SNY) stock saw a decline, ending the day at $49.23 which represents a decrease of $-0.64 or -1.28% from the prior close of $49.87. The stock opened at $49.13 and touched a low ...

Check the time stamp on this data. Updated AI-Generated Signals for Sanofi (SNY) available here: SNY.

Argus has recently reiterated Sanofi SA (SNY) stock to Buy rating, as announced on July 26, 2024, according to Finviz. Earlier, on January 23, 2024, Morgan Stanley had initiated the stock research ...

SNY's reasonable valuation, improving top-line performance, contributions from new product launches and positive pipeline ...

Former Knicks center Isaiah Hartenstein catches up with SNY NBA Insider Ian Begley to share his favorite memories from his season in New York, reacts to how the team has rebuilt after his departure, ...

Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Advanced Micro Devices, Inc. (AMD) and Sanofi (SNY), as well as two micro-cap stocks Team ...

On Jets Final Drive, SNY Jets reporter Jeane Coakley, SNY NFL Insider Connor Hughes, and The Ringer and SNY contributor John Jastremski explain what they think New York should do with their seventh ...